1. Change in REVEAL Lite 2 and COMPERA 2.0 risk status in patients with pulmonary arterial hypertension initiating oral treprostinil on dual background therapy: a retrospective chart review. (3rd October 2022) Authors: Frantz, R P; Shlobin, O A; Raina, A; Wu, B; Broderick, M; Classi, P; Sketch, M R Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Efficacy and dose-response relationship of oral treprostinil in PAH patients on monotherapy or dual background therapy. (3rd October 2022) Authors: Barbera, J A; Kiely, D; Gruenig, E; Balasubramanian, V; Vizza, C D; Elwing, J; Sood, N; Rao, Y; Holdstock, L; Seaman, S; Broderick, M; White, R J Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PM.78 Use of Intravenous Iron Sucrose Injections in the Treatment of Iron Deficiency Anaemia in Pregnancy. (26th April 2013) Authors: Butt, A; Broderick, M; Ciantar, E Journal: Archives of disease in childhood Issue: Volume 98(2013)Supplement 1 Page Start: A47 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗